(Q46748653)

English

Symptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPH to OROS MPH Results of a 3-week open-label study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220213

Symptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPH to OROS MPH Results of a 3-week open-label study (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220213

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Helmut Remschmidt

1

object named as

H Remschmidt

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

Aribert Rothenberger

4

object named as

A Rothenberger

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220213

author name string

P Hoare

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220213

C Ettrich

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220213

P Santosh

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220213

M Schmidt

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220213

Q Spender

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220213

R Tamhne

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220213

M Thompson

9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220213

C Tinline

10

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220213

G E Trott

11

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220213

R Medori

12

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220213

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220213

European Child & Adolescent Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220213

14

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220213

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220213

297-304

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220213

Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The differential validity of teacher ratings of inattention/overactivity and aggression

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attention-deficit hyperactivity disorder in children and youth: a quantitative systematic review of the efficacy of different management strategies

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00787-005-0467-6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220213

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220213

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46748653&oldid=2208068118"